Wockhardt Contract Manufacturing Services will be represented at two forthcoming industry conferences in the next two months. On 14th and 15th May, we will be at Progressive Clinical Manufacturing ...

Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for ...

The regulatory agency will review MSD’s new drug application (NDA) for Welireg under a Priority Review, with a Prescription ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Tevogen Bio has expanded its partnership with Microsoft, aiming to further their collaboration centred on AI and advance ...

The UK biotech sector raised £3.5bn in 2024, the highest annual total since 2021 when £4.5bn was raised. The UK biotech ...

The FDA has approved the sBLA of Eisai and Biogen's LEQEMBI for maintenance dosing indicated for the early stages of ...

Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.

The financial challenges facing clinical trials have created a more risk-averse landscape. Yet digital solutions could be the key for sponsors and CROs to optimize budgets and resources. We explore ...

Amgen has inaugurated its new drug substance facility in the US after announcing a $1bn further expansion at the North ...

Catalent, a global contract development and manufacturing organization (CDMO), has been recognized with two awards in the 2024 Pharmaceutical Technology Excellence Awards in the Innovation and Social ...

The Excellence Awards celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognize the people and companies that are driving change. Our program ...